MedPath

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

πŸ‡΅πŸ‡°Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Interaction Between Cocaine and Quetiapine - 1

Phase 1
Conditions
Cocaine-Related Disorders
First Posted Date
2004-07-16
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
12
Registration Number
NCT00087750
Locations
πŸ‡ΊπŸ‡Έ

Boston University Medical Center, Boston, Massachusetts, United States

Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1

Phase 2
Conditions
Substance-Related Disorders
First Posted Date
2004-07-07
Last Posted Date
2005-11-07
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
100
Registration Number
NCT00086398
Locations
πŸ‡ΊπŸ‡Έ

APT Residential Services Division, New Haven, Connecticut, United States

Tiagabine for the Treatment of Cocaine Dependence - 1

Phase 2
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
2004-06-30
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
140
Registration Number
NCT00086255
Locations
πŸ‡ΊπŸ‡Έ

Cincinnati VA Medical Center, Cincinnati, Ohio, United States

πŸ‡ΊπŸ‡Έ

Boston University Medical Center, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

University of Texas Hlth Sci Ctr Houston, Houston, Texas, United States

and more 1 locations

Baclofen for the Treatment of Cocaine Dependence - 1

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Interventions
Other: Placebo
First Posted Date
2004-05-12
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
160
Registration Number
NCT00082485
Locations
πŸ‡ΊπŸ‡Έ

San Francisco General Hosptial, San Francisco, California, United States

πŸ‡ΊπŸ‡Έ

Denver VA Medical Center, Denver, Colorado, United States

πŸ‡ΊπŸ‡Έ

South TX VA Health Care System, San Antonio, Texas, United States

and more 5 locations

Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2004-03-10
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
30
Registration Number
NCT00079560
Locations
πŸ‡ΊπŸ‡Έ

New York State Psychiatric Institute, New York, New York, United States

Bupropion for the Treatment of Methamphetamine Dependence - 1

Phase 2
Completed
Conditions
Amphetamine-Related Disorders
First Posted Date
2003-09-24
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
150
Registration Number
NCT00069251
Locations
πŸ‡ΊπŸ‡Έ

Matrix Institute on Addictions, Costa Mesa, California, United States

πŸ‡ΊπŸ‡Έ

South Bay Treatment Center, San Diego, California, United States

πŸ‡ΊπŸ‡Έ

Pacific Addiction Research Center, Honolulu, Hawaii, United States

and more 2 locations

Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

Phase 1
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
2003-08-25
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
16
Registration Number
NCT00067535
Locations
πŸ‡ΊπŸ‡Έ

Uniformed Services University of Health Science, Bethesda, Maryland, United States

Incentive Programs for Female Substance Abusers Who Smoke - 3

Phase 2
Completed
Conditions
Tobacco Use Disorder
First Posted Date
2003-07-16
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
90
Registration Number
NCT00064922
Locations
πŸ‡ΊπŸ‡Έ

Shields for Families, Inc., Los Angeles, California, United States

Maintenance Treatment for Abstinent Smokers

Phase 3
Completed
Conditions
Tobacco Use Disorder
Interventions
First Posted Date
2003-07-01
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
589
Registration Number
NCT00063323
Locations
πŸ‡ΊπŸ‡Έ

New York State Psychiatric Institute, New York, New York, United States

Substance Dependent Teens - Impact of Treating Depression Study 1 - 1

Phase 4
Completed
Conditions
Alcohol-Related Disorders
Marijuana Abuse
Substance-Related Disorders
Interventions
First Posted Date
2003-05-22
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
126
Registration Number
NCT00061113
Locations
πŸ‡ΊπŸ‡Έ

1611 South Federal Blvd., Denver, Colorado, United States

πŸ‡ΊπŸ‡Έ

University of Colorado Denver, Aurora, Colorado, United States

Β© Copyright 2025. All Rights Reserved by MedPath